Amgen, Inc. (AMGN)
321.41
-8.48
(-2.57%)
USD |
NASDAQ |
Dec 08, 15:27
Amgen Research and Development Expense (Quarterly): 1.90B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 369.60M |
| Gilead Sciences, Inc. | 1.334B |
| Johnson & Johnson | 3.693B |
| Eli Lilly & Co. | 3.466B |
| Regeneron Pharmaceuticals, Inc. | 1.338B |